|

HPV-based Screening Among Women 23-29 Years of Age

RECRUITINGN/ASponsored by Karolinska Institutet
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2020-11-16
Est. completion2038-12-31
Eligibility
Age23 Years – 29 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05229679

Summary

The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.

Eligibility

Age: 23 Years – 29 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women ages 23-29 invited to screening.

Exclusion Criteria:

* Women who do not show up for screening or do not consent.

Conditions4

CancerCervical CancerCervical Intraepithelial NeoplasiaHuman Papilloma Virus

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.